Suppr超能文献

在单一机构(印度)诊断的 34 例具有上皮分化的尤文肉瘤的临床病理、免疫组织化学、分子细胞遗传学特征及治疗和预后,包括 6 例具有“典型造釉细胞瘤样”特征的病例。

Clinicopathologic, immunohistochemical, molecular cytogenetic profile with treatment and outcomes of 34 cases of Ewing sarcoma with epithelial differentiation, including 6 cases with "Adamantinoma-like" features, diagnosed at a single institution, India.

机构信息

Department of Surgical Pathology, Tata Memorial Hospital, Parel Homi Bhabha National Institute(HBNI) University, Mumbai, India; Division of Molecular Pathology, Tata Memorial Hospital, Parel Homi Bhabha National Institute(HBNI) University, Mumbai, India.

Division of Molecular Pathology, Tata Memorial Hospital, Parel Homi Bhabha National Institute(HBNI) University, Mumbai, India.

出版信息

Ann Diagn Pathol. 2020 Dec;49:151625. doi: 10.1016/j.anndiagpath.2020.151625. Epub 2020 Sep 9.

Abstract

To analyze clinicopathological features, including treatment profile of 34 cases of Ewing sarcomas with epithelial differentiation, including 6 cases with adamantinoma-like features. EWSR1 gene rearrangement was tested by fluorescence in-situ hybridization. Thirty-four tumors occurred in 19 males and 15 females (M:F = 1.26:1), with age ranging from 7 to 61 years (average = 24.2); in extremities (17), pelvis (5), paraspinal region (6), head and neck region (3), abdomen (2) and lung (1). Prior to molecular testing, 20/34(58.8%) cases were unequivocally diagnosed as Ewing sarcomas. Histopathologically, the most commonly observed pattern was nesting-type, comprising malignant round cells, including adamantinoma-like features, seen in 6 tumors. Immunohistochemically, tumor cells were diffusely positive (cytoplasmic membranous staining) for CD99/MIC2 (34/34), Fli1 (30/30); focally for synaptophysin (4/16) (25%); variably positive for AE1/AE3(31/32)(96.8%), including diffuse immunoexpression in 4 cases; EMA(6/8) and p40(3/8). All 34 (100%) tumors, tested for EWSR1 rearrangement, displayed positive results. According to the treatment details (available in 24/34 cases, 70.5%), most patients (13/24)(54.1%) were treated with surgical resection and a specific chemotherapy(CT) regimen (neoadjuvant or adjuvant settings), including 7 patients, who received adjuvant radiotherapy. During follow-up (16 cases, 47%), 5 patients developed recurrences and 8 developed metastasis, including a single, who developed recurrence. Finally, 10 patients were alive-with-disease (2-22 months); 6 free-of-disease (5-36 months). This constitutes one of the largest documentation of these rare tumors from our subcontinent, which are diagnostically challenging; require molecular confirmation and associated with treatment implications.

摘要

分析 34 例具有上皮分化的尤文肉瘤的临床病理特征,包括 6 例具有典型造釉细胞瘤特征的病例。采用荧光原位杂交技术检测 EWSR1 基因重排。34 例肿瘤发生于 19 例男性和 15 例女性(男:女=1.26:1),年龄 7-61 岁(平均 24.2 岁);发生于四肢(17 例)、骨盆(5 例)、脊柱旁区(6 例)、头颈部(3 例)、腹部(2 例)和肺部(1 例)。在进行分子检测之前,20/34(58.8%)例病例被明确诊断为尤文肉瘤。组织病理学上,最常见的表现是巢状型,包括具有典型造釉细胞瘤特征的 6 例肿瘤中的恶性圆形细胞。免疫组化染色,肿瘤细胞弥漫性表达 CD99/MIC2(34/34)、Fli1(30/30);突触素(4/16)(25%)局灶性阳性;AE1/AE3(31/32)(96.8%)不同程度阳性,包括 4 例弥漫性免疫表达;EMA(6/8)和 p40(3/8)。34 例(100%)肿瘤均进行了 EWSR1 重排检测,结果均为阳性。根据治疗细节(24/34 例,70.5%),大多数患者(13/24)(54.1%)接受了手术切除和特定的化疗(CT)方案(新辅助或辅助治疗),包括 7 例患者接受了辅助放疗。在随访期间(16 例,47%),5 例患者复发,8 例患者发生转移,包括 1 例患者发生孤立性复发。最后,10 例患者疾病仍在(2-22 个月);6 例无疾病(5-36 个月)。这是南亚大陆此类罕见肿瘤的最大规模之一的文献记载,这些肿瘤具有诊断挑战性;需要分子确认,并与治疗意义相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验